At present, 750 Janaushadhi Kendras, providing more than 600 medicines and 150 medical devices, are operational and the target is to open 3,000 by end of this fiscal for achieving health safety, Chemicals and Fertilisers Minister Ananth Kumar today said.
He was speaking after signing of the Memorandum of Understanding (MoU) between the Bureau of Pharma PSUs of India (BPPI) and National Yuva Cooperative Society Ltd (NYCS) to set up 1,000 Janaushadhi Kendras across the country.
The price of generic medicines sold in the Janaushadhi Kendras is significantly lower than the average rate of leading brands, he said and cited some examples of comparable rates of anti-cancer and anti-diabetic medicines.
Kumar said the quality of the medicines provided in these Kendras would be 'WHO compliant'.
Stating that the government has increased the number of Janaushadhi Kendras from 99 to 750 in last two and half years, he said: "We are not satisfied. There should be 3,000, 5,000 Janaushadhi Kendras. It should be in each block and Gram Panchayat".
"We are in the discussions with the Health Ministry, drug controllers at the central as well as state levels for quick approvals to open Janaushadhi Kendras," he said.
BPPI is the nodal implementation agency for the PMBJP, which is an an initiative of the Department of Pharmaceuticals under the Chemicals and Fertilisers ministry to make quality medicines accessible to all citizens at an affordable price.
The PMBJP scheme would drastically reduce the out of pocket health expenditure for the common man and give an impetus to the Make in India mission in the pharma sector.
There is an active financial support extended by the government to the extent of Rs 2.5 lakh in the form of financial assistance to the Kendras set up in government hospitals and incentives to individuals, with special and softer terms to SC, ST and differently-abled persons.
Disclaimer: No Business Standard Journalist was involved in creation of this content
